This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum


  • 00
  • 00
  • 00
  • 00
7-9 March 2023
Westin Miyako KyotoKyoto, Japan

Yi Yang, Ph.D.
Lead Scientist at Ferring Pharmaceuticals A/S


Dr. Yi Yang obtained his Ph.D degree from Bielefeld University, Germany, in 2008 under the guidance of Prof. Dr. Norbert Sewald. He has been working at Lonza in Visp/Switzerland as a process chemist for peptide API process development, optimization, innovation, and GMP manufacturing. He is now working at Ferring Pharmaceuticals A/S as a lead scientist, focusing on the peptide API process development, optimization, innovation, and the management of the GMP manufacturing. Dr. Yi Yang has abundant experiences on peptide synthesis, side reaction/impurity analysis from both API manufacturing and formulation, process development/optimization/validation through QbD (Quality-by-Design), innovation, and GMP manufacturing including genotoxic impurity management, tech-transfer, risk assessment, operation, and regulatory management. Dr. Yi Yang holds a Lean-Six-Sigma Black Belt Certificate and published many articles as well as a monograph of “Side Reactions in Peptide Synthesis” (Academic Press).

Agenda Sessions

  • Peptide API Manufacturing Process Optimization through QbD Strategy